I might consider sharing my post-doctoral level analysis of Elite over the next 12 months, but certainly not before the snupdawg diamond hands post is made a sticky.
I might consider sharing my post-doctoral level analysis of Elite over the next 12 months, but certainly not before the snupdawg diamond hands post is made a sticky.
What's your doctorate degree level analysis of Elite over the next 12 months?
1. Are we going to the Nasdaq this year?
2. Are we going to merge with somebody this year? If not, perhaps next year?
3. What are the chances Nasrat proceeds forward with the ART tech for stimulant products as stated in the last CC?
4. What are the chances Nasrat proceeds forward with the ART tech for opioid products but specifically just for overseas to avoid any potential lawsuits as stated in the last CC?
5. Are we eventually going to get bought out? If so, what PPS and what timeframe?